SEC Form 4 · accession 0001179110-16-025873
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 2, 2016 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 2, 2016 | M | 27,085 | $3.19 | A | 196,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.19 | Jun 2, 2016 | M | 27,085 | D | Jun 8, 2007 | Jun 8, 2016 | Common Stock | 27,085 | 0 | D |
Explanation of responses
- F1Exercisable as to 21,667 shares commencing on June 8, 2007, 21,667 shares commencing on June 8, 2008, and 21,666 shares commencing on June 8, 2009.